Predicting COPD severity with a blood test
Part of Lungs & breathing clinical trials.
This study tests whether a blood marker called surfactant protein-D can help predict how severe a COPD flare-up is. If you are hospitalized for a COPD exacerbation, this trial may help researchers better understand your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older
- You must have a prior COPD diagnosis
- You must be admitted to the hospital for a sudden worsening of COPD symptoms
- You cannot have an active lung infection like tuberculosis or a fungal infection
- You cannot have other chronic lung diseases like asthma, interstitial lung disease, or lung cancer
- You must not be using steroids for reasons other than a COPD flare-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to help doctors decide if people having a COPD flare-up need antibiotics or steroids. It may help you get the right treatment faster and avoid unnecessary medications.
This study tests a software algorithm that uses your health data to predict if you might have a COPD exacerbation (flare-up) within 60 days after leaving the hospital. The goal is to catch problems early and help you stay healthier.
This study tests whether a wearable device and a smartphone app can predict when your COPD will flare up. It uses AI to spot early warning signs, so you might get help sooner.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study checks how exhaled breath changes over 6-month visits in people with COPD, to see if it can help track lung health over time. It may help find new ways to monitor your condition without invasive tests.
This trial tests a portable “positive pressure” breathing device in people with severe COPD to see how well it works and whether it’s safe. It may help if you have trouble breathing and meet the device and health requirements.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.